About this episode
Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health.
Comments
Rate this episode
Episode Details
- Author
- Dr. Frank Wiegand Chief Medical Officer Beckley Psytech, Kurt Rasmussen Ph.D. Chief Scientific Officer Delix Therapeutics, Clara Burtenshaw Co-founder and Partner Neo Kuma Ventures, PTSD, anxiety
- Show Type
- full
- Audio Format
- audio/mpeg